633 related articles for article (PubMed ID: 9091675)
41. Clinical management of BRCA1- and BRCA2-associated breast cancer.
Karp SE
Semin Surg Oncol; 2000 Jun; 18(4):296-304. PubMed ID: 10805951
[TBL] [Abstract][Full Text] [Related]
42. BRCA1 and BRCA2 gene mutations and risk of breast cancer. Public health perspectives.
Coughlin SS; Khoury MJ; Steinberg KK
Am J Prev Med; 1999 Feb; 16(2):91-8. PubMed ID: 10343884
[TBL] [Abstract][Full Text] [Related]
43. Attitudes, knowledge, and risk perceptions of women with breast and/or ovarian cancer considering testing for BRCA1 and BRCA2.
Bluman LG; Rimer BK; Berry DA; Borstelmann N; Iglehart JD; Regan K; Schildkraut J; Winer EP
J Clin Oncol; 1999 Mar; 17(3):1040-6. PubMed ID: 10071299
[TBL] [Abstract][Full Text] [Related]
44. What would you do? Specialists' perspectives on cancer genetic testing, prophylactic surgery, and insurance discrimination.
Matloff ET; Shappell H; Brierley K; Bernhardt BA; McKinnon W; Peshkin BN
J Clin Oncol; 2000 Jun; 18(12):2484-92. PubMed ID: 10856109
[TBL] [Abstract][Full Text] [Related]
45. Benefits and risks of screening mammography in women with BRCA1 and BRCA2 mutations.
Vaidya JS; Baum M
JAMA; 1997 Jul 23-30; 278(4):290. PubMed ID: 9228430
[No Abstract] [Full Text] [Related]
46. Benefits and risks of screening mammography in women with BRCA1 and BRCA2 mutations.
Gilson E
JAMA; 1997 Jul 23-30; 278(4):289-90; author reply 290. PubMed ID: 9228429
[No Abstract] [Full Text] [Related]
47. Breast carcinomas arising in carriers of mutations in BRCA1 or BRCA2: are they prognostically different?
Phillips KA; Andrulis IL; Goodwin PJ
J Clin Oncol; 1999 Nov; 17(11):3653-63. PubMed ID: 10550164
[TBL] [Abstract][Full Text] [Related]
48. Costs and benefits of diagnosing familial breast cancer.
Heimdal K; Maehle L; Møller P
Dis Markers; 1999 Oct; 15(1-3):167-73. PubMed ID: 10595273
[TBL] [Abstract][Full Text] [Related]
49. Genetic susceptibility testing and prophylactic oophorectomy.
Berchuck A; Carney ME; Futreal PA
Eur J Obstet Gynecol Reprod Biol; 1999 Feb; 82(2):159-64. PubMed ID: 10206409
[TBL] [Abstract][Full Text] [Related]
50. Coming to grips with genes and risk.
Kahn P
Science; 1996 Oct; 274(5287):496-8. PubMed ID: 8928001
[No Abstract] [Full Text] [Related]
51. Moral concerns of different types of patients in clinical BRCA1/2 gene mutation testing.
Goelen G; Rigo A; Bonduelle M; De Grève J
J Clin Oncol; 1999 May; 17(5):1595-600. PubMed ID: 10334549
[TBL] [Abstract][Full Text] [Related]
52. Ethical aspects of genetic counseling in familial breast and ovarian cancer. Combining applied theory and reflective practice.
Goelen G; Rigo A; Neyns B; Betz W; De Grève J
Ann N Y Acad Sci; 1997 Dec; 833():170-2. PubMed ID: 9616750
[No Abstract] [Full Text] [Related]
53. Determining carrier probabilities for breast cancer-susceptibility genes BRCA1 and BRCA2.
Parmigiani G; Berry D; Aguilar O
Am J Hum Genet; 1998 Jan; 62(1):145-58. PubMed ID: 9443863
[TBL] [Abstract][Full Text] [Related]
54. An update on DNA-based BRCA1/BRCA2 genetic counseling in hereditary breast cancer.
Lynch HT; Watson P; Tinley S; Snyder C; Durham C; Lynch J; Kirnarsky Y; Serova O; Lenoir G; Lerman C; Narod SA
Cancer Genet Cytogenet; 1999 Mar; 109(2):91-8. PubMed ID: 10087939
[TBL] [Abstract][Full Text] [Related]
55. Prophylactic surgery in women with a hereditary predisposition to breast and ovarian cancer.
Eisen A; Rebbeck TR; Wood WC; Weber BL
J Clin Oncol; 2000 May; 18(9):1980-95. PubMed ID: 10784640
[TBL] [Abstract][Full Text] [Related]
56. Deleterious mutations of both BRCA1 and BRCA2 in three siblings.
Loader S; Rowley PT
Genet Test; 1998; 2(1):75-7. PubMed ID: 10464601
[No Abstract] [Full Text] [Related]
57. Hereditary breast cancer.
Ellisen LW; Haber DA
Annu Rev Med; 1998; 49():425-36. PubMed ID: 9509273
[TBL] [Abstract][Full Text] [Related]
58. Molecular cancer genetics in eastern and central Europe.
Olah E
Dis Markers; 1999 Oct; 15(1-3):75-7. PubMed ID: 10595256
[No Abstract] [Full Text] [Related]
59. Genetic predisposition to breast cancer: a surgical perspective.
Sakorafas GH; Tsiotou AG
Br J Surg; 2000 Feb; 87(2):149-62. PubMed ID: 10671920
[TBL] [Abstract][Full Text] [Related]
60. Attitude towards prophylactic surgery and effects of genetic counselling in families with BRCA mutations. Austrian Hereditary Breast and Ovarian Cancer Group.
Wagner TM; Möslinger R; Langbauer G; Ahner R; Fleischmann E; Auterith A; Friedmann A; Helbich T; Zielinski C; Pittermann E; Seifert M; Oefner P
Br J Cancer; 2000 Apr; 82(7):1249-53. PubMed ID: 10755396
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
